Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Kraemer

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Data in Brief|August 28, 2019
Dataset of the frequency patterns of publications annotated to human protein-coding genes, their protein products and genetic relevanceMatthias Zwick, Oliver Kraemer, Adrian J Carter
Proteins|May 18, 2004
Virtual screening for inhibitors of human aldose reductaseOliver Kraemer, Isabelle Hazemann, Alberto D Podjarny, et al.
Molecular Informatics|July 28, 2016
Ensemble Rule-Based Classification of Substrates of the Human ABC-Transporter ABCB1 Using Simple Physicochemical DescriptorsMichael A Demel, Oliver Kraemer, Peter Ettmayer, et al.
Drug Discovery Today|July 7, 2019
Target 2035: probing the human proteomeAdrian J Carter, Oliver Kraemer, Matthias Zwick, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 14, 2012
Target binding properties and cellular activity of afatinib (BIBW 2992), an irreversible ErbB family blockerFlavio Solca, Goeran Dahl, Andreas Zoephel, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Data in Brief|August 28, 2019
Dataset of the frequency patterns of publications annotated to human protein-coding genes, their protein products and genetic relevanceMatthias Zwick, Oliver Kraemer, Adrian J Carter
Proteins|May 18, 2004
Virtual screening for inhibitors of human aldose reductaseOliver Kraemer, Isabelle Hazemann, Alberto D Podjarny, et al.
Molecular Informatics|July 28, 2016
Ensemble Rule-Based Classification of Substrates of the Human ABC-Transporter ABCB1 Using Simple Physicochemical DescriptorsMichael A Demel, Oliver Kraemer, Peter Ettmayer, et al.
Drug Discovery Today|July 7, 2019
Target 2035: probing the human proteomeAdrian J Carter, Oliver Kraemer, Matthias Zwick, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 14, 2012
Target binding properties and cellular activity of afatinib (BIBW 2992), an irreversible ErbB family blockerFlavio Solca, Goeran Dahl, Andreas Zoephel, et al.
Pageof 1